Crescent Biopharma, Inc.
Long

CBIO long, 4$ upside potential

130
CBIO, very low float, former runner, better earnings then expected, no real resistance before 10.50$, long there.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.